Strumento inattivo

Azioni Cellect Biotechnology Ltd

Azioni

Prezzo di chiusura TEL AVIV STOCK EXCHANGE Altri mercati azionari
- ^ILa	-

Cellect Biotechnology Ltd : Provides Corporate Update and Reports First Quarter 2017 Financial Results	29/05/17
Cellect Gets Green Light From FDA For ApoGraft IND Submission in the U.S.	03/05/17
Cellect Receives Notice of Intention to Grant from European Patent Office for Patent Protecting Company’s Technology in Multiple Indications	03/04/17
Cellect Biotechnology : Successful First Cancer Patient Stem Cell Transplant	27/03/17
Cellect Announces Successful First Cancer Patient Stem Cell Transplant	27/03/17

Settore

	Variaz. 1 gen.	Capi.
MODERNA, INC.	+41,79%	50,93 Mrd
IQVIA HOLDINGS INC.	-0,56%	42,12 Mrd
LONZA GROUP AG	+49,62%	42,05 Mrd
CELLTRION, INC.	-7,20%	29,18 Mrd
ICON PUBLIC LIMITED COMPANY	+12,59%	26,02 Mrd
ALNYLAM PHARMACEUTICALS, INC.	-21,51%	18,9 Mrd
BIO-TECHNE CORPORATION	+6,92%	13,21 Mrd
UNITED THERAPEUTICS CORPORATION	+24,91%	12,17 Mrd
MEDPACE HOLDINGS, INC.	+29,60%	12,16 Mrd